Coordinate positioning of MEF2 and myogenin binding sites

Gene

Volumn 172, Issue 1, 1996, Pages GC19-GC32

  Fickett, James W ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

MEF2; MyoD family; Myogenin; Transcriptional regulation

Indexed keywords

MYOGENIN; REPETITIVE DNA; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; HUMAN; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN NUCLEIC ACID INTERACTION; SKELETAL MUSCLE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CONSERVED SEQUENCE; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); EVOLUTION; HUMANS; MOLECULAR SEQUENCE DATA; MYOGENIC REGULATORY FACTORS; MYOGENIN; OLIGODEOXYRIBONUCLEOTIDES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0029935832     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-1119(95)00888-8     Document Type: Article

References (74)

1. Davis, R.L., Weintraub, H. and Lassar, A.B. (1987) Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987-1000.
2. Emerson, C.P. (1990) Myogenesis and developmental control genes. Curr. Opin. Cell Biol. 2, 1065-1075.
3. Weintraub, H. (1993) The MyoD family and myogenesis: Redundancy, networks, and thresholds. Cell 75, 1-20.
4. Buckingham, M. (1994) Muscle differentiation. Which myogenic factors make muscle? Curr. Biol. 4, 61-63.
5. Olson, E.N. and Klein, W.H. (1994) bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8, 1-8.
6. Murre, C., Bain, G., van Dijk, M.A., Engel, I., Furnari, B.A., Massari, M.E., Matthews, J.R., Quong, M.W., Rivera, R.R., and Stuiver, M.H. (1994) Structure and function of helix-loop-helix proteins. Biochem. Biophys. Acta 1218, 129-135.
7. Rudnicki, M.A., Schnegelsberg, P.N., Stead, R.H., Braun, T., Arnold, H.H., and Jaenisch, R. (1993) MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75, 1351-1359.
8. Hasty, P., Bradley, A., Morris, J.H., Edmondson, D.G., Venuti, J.M., Olson, E.N., and Klein, W.H. (1993) Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364, 501.
9. Nabeshima, Y. Hanaoka, K., Hyasaka, M., Esumi, E., Li, S., Nonaka, M., and Nabeshima, Y. (1993) Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364, 532-535.
10. Gossett L. A., Kelvin, D.J., Sternberg, E.A. and Olson, E.N. (1989) A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol. Cell. Biol. 9, 5022-5033.
11. Nakatsuji, Y., Hidaka, K., Tsujino, S., Yamamoto, Y., Mukai, T., Yanagihara, T., Kishimito, T. and Sakoda, S. (1992) A single MEF2 site is a major positive regulatory element required for transcription of the muscle-specific subunit for the human phosphoglycerate mutase gene in skeletal and cardiac muscle cells. Mol. Cell. Biol. 12, 4384-4390.
12. Cserjesi P. and Olson, E.N. (1991) Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol. Cell. Biol. 11, 4854-4862.
13. Kaushal, S., Schneider, J.W., Nadal-Ginard, B., and Mahdavi, V. (1994) Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD. Science 266, 1236-1240.
14. Edmondson, D.G., Cheng, T.-C., Cserjesi, P., Chakraborty, T. and Olson, E.N. (1992) Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol. Cell. Biol. 12, 3665-3677.
15. Lilly, B., Zhao, B., Ranganayakulu, G., Paterson, B.M., Schulz, R.A. and Olson, E.N. (1995) Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science 267, 688-693.
16. Breitbart, R.E., Liang, C.-S., Smoot, L.B., Laheru, D.A., Mahdavi, V., Nadal-Ginard, B. (1993) A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. Development (Camb.) 118, 1095-1106.
17. Martin, J.F., Miano, J.M., Hustad, C.M., Copeland, N.G., Jenkins, N.A. and Olson, E.N. (1994) A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol. Cell. Biol. 14, 1647-1656.
18. Shore, P. and Sharrocks, A.D. (1995) The MADS-box family of transcription factors. Eur. J. Biochem. 279, 1-13.
19. Weintraub, H., Davis, R., Lockshon, D., and Lassar, A. (1990) MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc. Natl. Acad. Sci. USA 87, 5623-5627.
20. Martin, K.A., Walsh, K., and Mader, S.L. (1994) The mouse creatine kinase paired E-box element confers muscle-specific expression to a heterologous promoter. Gene 142, 275-278.
21. Chakraborty, T., Brennan, T., and Olson, E. (1991) Differential trans-activation of a muscle-specific enhancer by myogenic helix-loop-helix proteins is separable from DNA binding. J. Biol. Chem. 266, 2878-2882.
22. Johnson, J.E., Birren, S.J., Saito, T., and Anderson, D.J. (1992) DNA binding and transcriptional regulatory activity of mammalian achaete-scute homologous (MASH) proteins revealed by interaction with a muscle-specific enhancer. Proc. Natl. Acad. Sci. USA 89, 3596-3600.
23. Weintraub, H., Genetta, T., and Kadesch, T. (1994) Tissue-specific gene activation by MyoD: determination of specificity by cis-acting repression elements. Genes Dev. 8, 2203-2211.
24. Li, Z. and D. Paulin. 1993. Different factors interact with myoblast-specific and myotube-specific enhancer regions of the human desmin gene. J. Biol. Chem. 268, 10403-10415.
25. Jaynes, J.B., Johnson, J.E., Buskin, J.N., Gartside, C.L., and Hauschka, S.D. (1988). The muscle creatine kinase gene is regulated by multiple upstream elements, including a muscle-specific enhancer. Mol. Cell. Biol. 8, 62-70.
26. Sternberg, E.A., Spizz, G., Perry, W.M., Vizard, D., Weil, T., and Olson, E.N. (1988) Identification of upstream and intragenic regulatory elements that confer cell-type-restricted and differentiation-specific expression on the muscle creatine kinase gene. Mol. Cell. Biol. 8, 2896-2909.
27. Salminen, A., Braun, T., Buchberger, A., Juers, S., Winter, B., and Arnold, H.-H. (1991). Transcription of the muscle regulatory gene MYF4 is regulated by serum components, peptide growth factors and signaling pathways involving G proteins. J. Cell. Biol. 115, 905-917.
28. Buchberger, A., Ragge, K., and Hans-Henning, A. (1994). The myogenin gene is activated during myocyte differentiation by preexisting, not newly synthesized transcription factor MEF2. J. Biol. Chem. 269, 17289-17296.
29. Donoghue, M., Ernst, H., Wentworth, B., Nadal-Ginard, B., and Rosenthal, N.(1988) A muscle-specific enhancer is located at the 3′ end of the myosin light-chain 1/3 gene locus. Genes Dev. 2, 1779-1790.
30. Rosenthal, N., Berglund, E.B., Wentworth, B.M., Donoghue, M., Winter, B., Bober, E., Braun, T. and Arnold, H.-H. (1990) A highly conserved enhancer downstream of the human MLC1/3 locus is a target for multiple myogenic determination factors. Nucl. Acids Res. 18, 6239-6246.
31. Black, B.L., Martin, J.F. and Olson, E.N. (1995) The mouse MRF4 promoter is trans-activated directly and indirectly by muscle-specific transcription factors. J. Biol. Chem. 270, 2889-2892.
32. Naidu, P.S., Ludolph, D.C., To, R.Q., Hinterberger, T.J., and Konieczny, S.F. (1995) Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis. Mol. Cell. Biol. 15, 2707-2718.
33. Funk, W.D. and Wright, W.E. (1992) Cyclic amplification and selection of targets for multicomponent complexes: myogenin interacts with factors recognizing binding sites for basic helix-loop-helix, nuclear factor 1, myocyte-specific enhancer-binding factor 2, and COMP1 factor. Proc. Natl. Acad. Sci. USA 89, 9484-9488.
34. Davis, R.L., Cheng, P.F., Lassar, A.B. and Weintraub, H. (1990) The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell 60, 733-746.
35. Cheng, T.-S., Wallace, M.C., Merlie, J.P., Olson, E.N. (1993). Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science 261, 215-218.
36. Yee, S.-P., and Rigby, P. (1993). The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev. 7, 1277-1289.
37. Pollock, R. and Treisman, R. (1991) Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev. 5, 2327-2341.
38. Lawrence, C.E., Altschul, S.F., Boguski, M.S., Liu, J.S., Neuwald, A. and Wootton, J.C (1993) Detecting subtle sequence signals: a Gibbs sampling strategy for multiple alignment. Science 262, 208-214.
39. Stormo, G.D. (1990) Consensus patterns in DNA. In R.F. Doolittle (Ed.), Molecular Evolution: Computer Analysis of Protein and Nucleic Acid Sequences, Special issue. Methods Enzymol. 183: 211-220.
40. Fickett, J.W. (1995) Computational gene identification: under the hood. In H.O Villar (Ed.), Advances in Computational Biology, in press.
41. Berg, O.G. and von Hippel, P.H. (1988) Selection of DNA binding sites by regulatory proteins. Trends Biochem. Sci. 13, 207-211.
42. Von Hippel, P.H. (1994) Protein-DNA recognition: new perspectives and underlying themes. Science 263, 769-770.
43. Fickett, J.W. (1995) Quantitative discrimination of MEF2 sites. Mol. Cell. Biol., in press.
44. Li, H. and Capetanaki, Y. (1993) Regulation of the mouse desmin gene: transactivation by MyoD, myogenin, MRF4 and Myf5. Nucl. Acids Res. 21, 335-343.
45. Cserjesi, P., Lilly, B., Bryson, L., Wang, Y., Sassoon, D.A., and Olson, E.N. (1992). MHox: a mesodermally restricted homeodomain protein that binds an essential site in the muscle creative kinase enhancer. Development (Camb.) 115, 1087-1101.
46. Cserjesi, P., Lilly, B., Hinkley, C., Perry, M., and Olson, E.N. (1994) Homeodomain protein MHox and MADS protein myocyte enhancer-binding factor-2 converge on a common element in the muscle creatine kinase enhancer. J. Biol. Chem. 269, 16740-16745.
47. Brennan, T.J. and Olson, E.N. (1990) Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization. Genes Dev. 4, 582-595.
48. Wentworth, B.M., Donoghue, M., Engert, J.C., Berglund, E.B. and Rosenthal, N. (1991) Paired MyoD binding sites regulate myosin light chain gene expression. Proc. Natl. Acad. Sci. USA 88, 1242-1246.
49. Wang, J.C. (1979) Helical repeat of DNA in solution. Proc. Natl. Acad. Sci. USA 76, 200-203.
50. Rhodes, D. and Klug, A. (1980) Helical periodicity of DNA determined by enzyme digestion. Nature 286, 573-578.
51. Li, H., and Capetanaki, Y. (1994). An E box in the desmin promoter cooperates with the E box and MEF-2 sites of a distal enhancer to direct muscle-specific transcription. EMBO J. 13, 3580-3589.
52. Venuti, J.M., Goldberg, L., Chakraborty, T., Olson, E.N., and Klein, W.H. (1991) A myogenic factor from sea urchin embryos capable of programming muscle differentiation in mammalian cells. Proc. Natl. Acad. Sci. USA 88, 6219-6223.
53. Atchley, W.R., Fitch, W.M., and Bronner-Fraser, M. (1994) Molecular evolution of the MyoD family of transcription factors. Proc. Natl. Acad. Sci. USA 91, 11522-11526.
54. Sabina, R.L., Morisaki, T., Clarke, P., Eddy, R., Shows, T.B., Morton, C.C. and Holmes, E.W. (1990) Characterization of the human and rat myoadenylate deaminase genes. J. Biol. Chem. 265, 9423-9433.
55. Taylor, J.M., Davies, J.D., and Peterson, C.A. (1995) Regulation of the myoblast-specific expression of the human b-enolase gene. J. Biol. Chem. 270, 2535-2540.
56. Konieczny, S.F. and Emerson, C.P.Jr. (1987) Complex regulation of the muscle-specific contractile protein (troponin I) gene. Mol. Cell. Biol. 7, 3065-3075.
57. Coleman, M.E., DeMayo, F., Kuo, C.Y., Lee, H.M., Geske, R., Montgomery, C., and Schwartz, R.J. (1995) Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertophy in transgenic mice. J. Biol. Chem. 270, 12109-12116.
58. Hall, L.J., Kajimoto, Y., Bichell, D., Kim, S.W., James, P.L., Counts, D., Nixon, L.J., Tobin, G., and Rotwein, P. (1992) Functional analysis of the rat insulin-like growth factor I gene and identification of an IGF-I gene promoter. DNA Cell Biol. 11, 301-313.
59. Pash, J.M., Delany, A.M., Adamo, M.L., Roberts, C.T., LeRoith, D., and Canalis, E. (1995) Regulation of insulin-like growth factor I transcription by prostaglandin E2 in osteoblast cells. Endocrinology 136, 33-38.
60. Nolten, L.A., vanSchaik, F.M., Steenbergh, P.H. and Sussenbach, J.S. (1994) Expression of the insulin-like growth factor I gene is stimulated by the liver-enriched transcription factors C/EBP alpha and LAP. Mol. Endocrinol. 8, 1636-1645.
61. Thomas, M.J., Kikuchi, K., Bichell, D.P., and Rotwein, P. (1994) Rapid activation of rat insulin-like growth factor-I gene transcription by growth hormone reveals no alterations in deoxyribonucleic acid-protein interactions with the major promoter. Endocrinology 135, 1584-1592.
62. Kulik, V.P, Kavsan, V.M., van Schaik, F.M.A., Nolten, L.A., Steenbergh, P.H., and Sussenbach, J.S. (1995) The promoter of the salmon insulin-like growth factor I gene is activated by hepatocyte nuclear factor I. J. Biol. Chem. 270, 1068-1073.
63. Le Stunff, C., Thomas, M.J., and Rotwein, P. (1995) Rapid activation of rat insulin-like growth factor-I gene transcription by growth hormone reveals no changes in deoxyribonucleic acid-protein interactions within the second promoter. Endocrinology 136, 2230-2237.
64. Lowe, W.L. and Teasdale, R.M. (1992) Characterization of a rat insulin-like growth factor gene promoter. Biochem. Biophys. Res. Commun. 189, 972-978.
65. D'Ercole, A.J., Stiles, A.D. and Underwood, L.W. (1984) Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc. Natl. Acad. Sci. USA 81, 935-939.
66. Han, V.K., D'Ercole, A.J., and Lund, P.K. (1987) Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236, 193-197.
67. Koval, A., Kulik, V., Duguay, S., Plisetskaya, E., Adamo, M.L., Roberts, C.T.Jr., Leroith, D., and Kavsan, V. (1994) Characterization of a salmon insulin-like growth factor promoter. DNA Cell Biol. 13, 1057-1062.
68. Huang, S., Thule, P.M. and Phillips, L.S. (1995) Identification of novel promoter and repressor elements in the 5′ flanking regions of the rat insulin-like growth factor 1 gene. Biochem. Biophys. Res. Commun. 206, 279-286.
69. Kadesch, T., Zervos, P. and Ruezinsky, D. (1986) Functional analysis of the murine IgH enhancer: evidence for negative control of cell-type specificity. Nucl. Acids Res. 14, 8209-8221.
70. Ma, P.C.M., Rould, M.A., Weintraub, H. and Pabo, C.O. (1994) Crystal structure of MyoD bHLH domain-DNA complex: perspectives on DNA recognition and implications for transcriptional activation. Cell 77, 451-459.
71. Pellegrini, L., Tan, S., Richmond, T.J. (1994) Structure of serum response factor core bound to DNA. Nature 376, 490-498.
72. Bucher, P. (1990) Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212, 563-578.
73. Prestridge, D.S. (1995) Predicting Pol II promoter sequences using transcription factor binding sites. J. Mol. Biol. 249, 923-932.
74. Blackwell, T.K. and Weintraub., H. (1990) Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250, 1104-1110.